Foresee Pharmaceuticals Co Ltd (6576) — Financial Flexibility Index
Foresee Pharmaceuticals Co Ltd (6576) has a Financial Flexibility Index of -0.25x as of June 2025. Free cash flow of NT$-151.26 Million (operating CF NT$-157.53 Million minus capex NT$6.26 Million) represents 0% of total liabilities (NT$593.99 Million). Also explore net asset growth rate of Foresee Pharmaceuticals Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Foresee Pharmaceuticals Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Foresee Pharmaceuticals Co Ltd across 8 annual periods. Check 6576 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Foresee Pharmaceuticals Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Foresee Pharmaceuticals Co Ltd. For the full company profile including market capitalisation, see Foresee Pharmaceuticals Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.82x | NT$-1.02 Billion | NT$-1.17 Billion | NT$560.15 Million | ▼ -33.2% |
| 2023 | -1.36x | NT$-841.27 Million | NT$-887.55 Million | NT$616.93 Million | ▼ -206.3% |
| 2022 | -0.45x | NT$-175.16 Million | NT$-233.22 Million | NT$393.43 Million | ▲ +30.5% |
| 2021 | -0.64x | NT$-205.69 Million | NT$-213.33 Million | NT$321.26 Million | ▲ +73.2% |
| 2020 | -2.39x | NT$-646.61 Million | NT$-674.80 Million | NT$270.40 Million | ▲ +24.9% |
| 2019 | -3.19x | NT$-361.29 Million | NT$-447.82 Million | NT$113.40 Million | ▲ +10.5% |
| 2018 | -3.56x | NT$-448.33 Million | NT$-462.43 Million | NT$125.99 Million | ▲ +23.9% |
| 2017 | -4.68x | NT$-465.18 Million | NT$-483.10 Million | NT$99.44 Million | — |